Return to Publications
August 2018
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Prostate Cancer study

$26.5M Grant Helps Investigators 'RESPOND' to Prostate Cancer

Rutgers Cancer Institute of New Jersey, the New Jersey State Cancer Registry and the New Jersey Department of Health are collaborating on a $26.5 million study examining why African-American men develop more aggressive forms of prostate cancer. The 'RESPOND' study is being led by the Keck School of Medicine at USC in conjunction with local investigators New Jersey State Cancer Registry Director Antoinette Stroup, PhD, of Rutgers Cancer Institute and Karen Pawlish, PhD, of the New Jersey Department of Health. 

Anita Kinney, PhD

Improving Public Health by Understanding Cancer Risk

Aiming to reduce cancer risk, improve the understanding of cancer outcomes, and promote cancer health equity in our most vulnerable populations at the community level, the Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey recently welcomed Anita Y. Kinney, PhD, as Director of the Center of Cancer Health Disparities at the Rutgers School of Public Health and Associate Director of Cancer Health Equity and Engagement at Rutgers Cancer Institute.

Tobacco 21

$3M Grant Supports Rutgers Initiative to Study Tobacco 21 Laws

Rutgers researchers, with the aid of a new $3 million National Cancer Institute grant, will be studying the effectiveness of Tobacco 21 laws with the aim of improving the health of young people. Cristine Delnevo, PhD, vice dean and director of the Center for Tobacco Studies at Rutgers School of Public Health and co-leader of the Cancer Prevention and Control Research Program at Rutgers Cancer Institute of New Jersey; and Shawna Hudson, PhD, professor and research division chief, Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute researcher, are leading the effort.

designation

Recognized for Quality in Value-Based Cancer Care

Rutgers Cancer Institute of New Jersey and its partner, RWJBarnabas Health have been recognized with a Blue Distinction® Centers for Cancer Care designation as part of the Blue Distinction Specialty Care program. By combining nationally consistent quality criteria with locally effective value-based programs, Blue Distinction Centers for Cancer Care deliver maximum value to members battling cancer by aligning health care payments with improved health outcomes. The designation is available for all cancer types and various care settings.

Darren Carpizo, MD, PhD

Understanding an 'On/Off' Switch in a Commonly Mutated Cancer Gene

Rutgers Cancer Institute of New Jersey researchers have elucidated the mechanism behind an 'on/off' switch in the the most commonly mutated gene in human cancer - p53. Senior investigator Darren R. Carpizo, MD, PhD, director of the Hepatobiliary Cancer Program and associate professor of surgery and pharmacology at Rutgers Robert Wood Johnson Medical School, says the findings could lead to a new paradigm in cancer therapeutics. The work was published in the online first version of Clinical Cancer Research on June 18.

Century

Propelling Cancer Research on Two Wheels

Aiming to add to the $2.25 million raised over the past 13 years, organizers of the annual Century for the Cure bike ride that supports research at Rutgers Cancer Institute of New Jersey are gearing up for another successful event. The ride features route options of 100, 62, 40 and 25 miles and opportunities to participate as a 'virtual' rider and volunteer are also available. Registration for this year's September 30 event in Warren Township is open at www.centuryforthecure.com.